Article Versions Notes

Neves A, Albuquerque T, Faria R, Santos CRA, Vivès E, Boisguérin P, Carneiro D, Bruno DF, Pavlaki MD, Loureiro S, et al. Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells. Pharmaceutics. 2024; 16(6):781. https://doi.org/10.3390/pharmaceutics16060781

Neves, Ana, Tânia Albuquerque, Rúben Faria, Cecília R. A. Santos, Eric Vivès, Prisca Boisguérin, Diana Carneiro, Daniel F. Bruno, Maria D. Pavlaki, Susana Loureiro, and et al. 2024. "Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells" Pharmaceutics 16, no. 6: 781. https://doi.org/10.3390/pharmaceutics16060781

Neves, A., Albuquerque, T., Faria, R., Santos, C. R. A., Vivès, E., Boisguérin, P., Carneiro, D., Bruno, D. F., Pavlaki, M. D., Loureiro, S., Sousa, Â., & Costa, D. (2024). Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells. Pharmaceutics, 16(6), 781. https://doi.org/10.3390/pharmaceutics16060781